Skip to main content

Acetazolamide

NDC 69367-209 · Westminster Pharmaceuticals, LLC

Generic nameAcetazolamide
Dosage formCAPSULE, EXTENDED RELEASE
RouteORAL
Active ingredient(s)ACETAZOLAMIDE
Strength500 mg/1
Pharmacologic classCarbonic Anhydrase Inhibitor [EPC], Carbonic Anhydrase Inhibitors [MoA], Sulfonamides [CS]
Marketing categoryANDA

Packages

69367-209-01 — 100 CAPSULE, EXTENDED RELEASE in 1 BOTTLE (69367-209-01)

Related Codes

Same active ingredient

FDA lists these products with the same active ingredient.

62135-612 — Acetazolamide, 62332-349 — Acetazolamide, 63629-1194 — Acetazolamide, 63629-1195 — Acetazolamide, 64380-833 — Acetazolamide, 64380-834 — Acetazolamide, 65841-762 — acetazolamide, 68071-3550 — Acetazolamide, 68071-3632 — acetaZOLAMIDE, 68071-3728 — Acetazolamide, 70518-4646 — Acetazolamide, 70710-1238 — acetaZOLAMIDE, 70710-1239 — acetaZOLAMIDE, 70710-1591 — acetazolamide, 70756-720 — Acetazolamide, 70756-721 — Acetazolamide, 70771-1827 — acetaZOLAMIDE, 70771-1828 — acetaZOLAMIDE, 70954-033 — Acetazolamide, 70954-034 — Acetazolamide, +44 more

Poisoning, adverse-effect and underdosing codes for this drug

The ICD-10-CM Table of Drugs and Chemicals carries these diagnosis codes for this drug — a drug-name match derived from FDA's product name and the Table of Drugs and Chemicals, not a CMS-published pairing.

T50.2X1 — Poisoning by carbonic-anhydrase inhibitors, benzothiadiazides and other diuretics, accidental (unintentional), T50.2X2 — Poisoning by carbonic-anhydrase inhibitors, benzothiadiazides and other diuretics, intentional self-harm, T50.2X3 — Poisoning by carbonic-anhydrase inhibitors, benzothiadiazides and other diuretics, assault, T50.2X4 — Poisoning by carbonic-anhydrase inhibitors, benzothiadiazides and other diuretics, undetermined, T50.2X5 — Adverse effect of carbonic-anhydrase inhibitors, benzothiadiazides and other diuretics, T50.2X6 — Underdosing of carbonic-anhydrase inhibitors, benzothiadiazides and other diuretics